Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinoma.
Journal Information
Full Title: J Pathol Clin Res
Abbreviation: J Pathol Clin Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest statement: The authors declare no potential conflicts of interest. A patent application for the use of ADPR staining has been filed by the University of Zurich."
Funding Disclosure
Evidence found in paper:
"This work was supported by the Cancer Research Center of the University of Zurich (FA), the Kanton of Zurich, the University Research Priority Program (URPP) in Translational Cancer Research (University of Zurich) and the Swiss National Science Foundation (grant 310030_176177 and 310030_205202 to MOH)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025